arrow
M

Manon A. A. Jansen

centre for human drug research
H指数:12
被引数:523

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characterization of the Immune Response after Oral Cholera Vaccination (OCV) and Effects of Mycophenolate Mofetil on Priming of this Immune Response—A Randomized, Placebo-Controlled Trial

口服霍乱疫苗接种后免疫反应的表征及霉酚酸吗啉对启动该免疫反应的影响——一项随机、安慰剂对照试验

2026-08-290
OAAI
IL-2 mutein-engrafted antibody MHS552 selectively expands functional regulatory T cells in nonclinical models and healthy participants

IL-2 mutein-engrafted抗体MHS552在非临床模型和健康受试者中选择性扩增功能性调节性T细胞

2026-08-120
OA
First-In-Human Safety, Pharmacokinetics, and Pharmacodynamics of VENT-02 Freebase, a CNS-Penetrant NLRP3 Inhibitor

VENT-02游离碱作为中枢神经系统穿透性NLRP3抑制剂的首次人体安全性、药代动力学和药效学研究

2026-04-300
OAAI
Repeated intradermal lipopolysaccharide challenge responses in healthy volunteers: Implications for clinical pharmacology studies

在健康志愿者中重复皮内脂多糖挑战反应:对临床药理学研究的意义

2026-04-220
OAAI
Intravenous Lipopolysaccharide Challenge in Healthy Participants Reveals Pharmacodynamic Markers in Blood and Bone Marrow for Early-Phase Oncology Drug Development

静脉脂多糖挑战在健康受试者中揭示血液和骨髓的药效学标志物,用于早期肿瘤药物开发

2026-04-140
OAAI
Breaking Barriers: Characterization of the Intradermal Lipopolysaccharide Challenge as an In Vivo Model for Controlled Induction of Vascular Leakage in Healthy Volunteers

突破壁垒:作为健康志愿者中血管渗漏可控诱导的体内模型,皮内脂多糖挑战的特征描述

2025-11-150
OAAI
Adverse immunostimulation in early phase clinical trials: Key findings and recommendations based on the investigator's clinical experience

早期临床试验中的不良免疫刺激:基于研究者临床经验的关键发现和建议

2025-09-010
OAAI
Profiling a Neo-Antigen-Driven Immune Response in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Study of the KLH Challenge Model

在健康志愿者中分析新抗原驱动的免疫反应:KLH挑战模型的一项随机、双盲、安慰剂对照研究

2025-07-220
OAAI
Intradermal lipopolysaccharide challenge as an acute in vivo inflammatory model in healthy volunteers
2021-08-2410
OAAI